Company facts
- Headquarters
- Hackensack, New Jersey
- Most recent report
- 10-Q, filed Aug 12, 2026
- Incorporated
- Delaware
- Filings on record
- 962 filings
- On EDGAR
- CIK 1006281
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer Smaller reporting company
Financials 8 of 103
News 8 of 342
- 8-K Quarterly results Aug 12, 2026
- 8-K Shareholder vote results Jun 25, 2026
- 8-K Current report on a material event May 21, 2026
- 8-K Quarterly results May 13, 2026
- 8-K Quarterly results Mar 18, 2026
- 8-K Other events Mar 9, 2026
- 8-K Current report on a material event Feb 11, 2026
- 8-K Other events Jan 30, 2026
Prospectuses and Registrations 8 of 41
- S-8 Registration statement for an employee plan Aug 12, 2026
- 424B5 Prospectus supplement for an offering Aug 22, 2025
- S-3/A Shelf registration statement, amended Aug 14, 2025
- S-3 Shelf registration statement Apr 28, 2025
- 424B5 Prospectus supplement for an offering Mar 17, 2025
- S-8 Registration statement for an employee plan Jul 1, 2024
- S-8 Registration statement for an employee plan Aug 11, 2023
- 424B3 Prospectus supplement for an offering Jul 7, 2023
Proxies 8 of 53
- DEF 14A Proxy statement for a shareholder vote Apr 30, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 30, 2025
- DEFA14A Extra proxy material May 17, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2024
- DEFA14A Extra proxy material Jun 28, 2023
- DEF 14A Proxy statement for a shareholder vote May 18, 2023
- PRE 14A Preliminary proxy statement May 2, 2023
- DEFA14A Extra proxy material Jun 16, 2022
Ownership 8 of 302
- SCHEDULE 13G Large holder reported a passive stake Jul 29, 2026
- 3/A Insider reported their initial holding, amended Apr 27, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Mar 30, 2026
- SCHEDULE 13G Large holder reported a passive stake Mar 4, 2026
- 4 Insider reported a trade Dec 23, 2025
- 4 Insider reported a trade Nov 19, 2025
- 4 Insider reported a trade Sep 4, 2025
- 4 Insider reported a trade Sep 4, 2025
Other 8 of 121
- ARS Annual report sent to shareholders Apr 30, 2026
- EFFECT Notice that a registration became effective Aug 22, 2025
- CORRESP Reply to SEC staff Aug 20, 2025
- ARS Annual report sent to shareholders May 8, 2025
- UPLOAD Comment letter from SEC staff Apr 30, 2025
- ARS Annual report sent to shareholders May 17, 2024
- ARS Annual report sent to shareholders May 19, 2023
- UPLOAD Comment letter from SEC staff Jun 30, 2022
Everything here comes from Protalix BioTherapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.